SCHEMBL19207928

SCHEMBL19207928

CCOC(=O)C(N)=NNC(=O)C1CCc2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 3/20 0.42
KCNQ2 O43526 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.39
ANO1 Q5XXA6 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 2/20 0.37
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ROCK1 Q13464 1/20 0.36
MTNR1A P48039 2/20 0.36
MTNR1B P49286 2/20 0.36
ACKR3 P25106 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19224562 1.00 PIN1 (0.42) PIN1KCNQ2SMN1; SMN2ANO1MEN1
SCHEMBL19207927 1.00 PIN1 (0.42) PIN1KCNQ2SMN1; SMN2ANO1MEN1
SCHEMBL7419740 0.76 PIN1 (0.51) PIN1KCNQ2ANO1ALDH1A1MTNR1A
SCHEMBL4720088 0.76 PIN1 (0.52) PIN1MEN1KMT2AGAAALDH1A1
SCHEMBL8301042 0.75 PIN1 (0.47) PIN1KCNQ2ANO1MEN1KMT2A
SCHEMBL19985038 0.74 PIN1 (0.46) PIN1KCNQ2ANO1MEN1KMT2A
SCHEMBL28937024 0.73 PIN1 (0.56) PIN1KCNQ2ANO1MEN1KMT2A
SCHEMBL22509049 0.71 PIN1 (0.39) PIN1KCNQ2ANO1MEN1KMT2A
SCHEMBL10469672 0.71 PIN1 (0.54) PIN1KCNQ2ANO1ROCK1ACKR3
SCHEMBL19207602 0.71 PIN1 (0.54) PIN1KCNQ2ANO1ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114437105-A Inhibitors of receptor interacting protein kinase 1 戴纳立制药公司 2022-05-06 CN disclosed
CN-109071504-B Inhibitors of receptor interacting protein kinase 1 戴纳立制药公司 2022-03-08 CN disclosed
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed